
Survodutide
A dual GLP-1 and glucagon receptor agonist investigated for metabolic and hepatic endpoints.
Read the Survodutide research guide→Low stock, order soon
✓ 100% purity-match & safe-arrival guarantee
✓ Orders placed before 2:00 PM CT on a business day ship the same day.
✓ Free shipping over $200. One discount per order.
- Best value!Make this a kitSurvodutide + 3 mL BAC water + 10 syringes + 10alcohol pads — pads free, water & syringes 25% offStarting at$114.11$122.14
- Bacteriostatic Water0.9% benzyl alcohol water for reconstitution, sold as a single vial.$13.14
- Insulin Syringes31G 0.5 mL sterile syringes, sold in packs of 10, 100, or 300.$7
- Alcohol Prep Pads70% isopropyl alcohol pads, sold in packs of 10 or 200.$3
Molecular specification
- Molecular formula
- C207H332N50O64
- Molecular weight
- 4488.9 g/mol
- CAS number
- 2072664-80-3
- Amino acids
- 40
- Appearance
- White lyophilized powder
- Purity (HPLC)
- 98.8%
- Elimination half-life
- ≈ 5 days (109–115 h)
Mechanism & published research
Co-agonism at GLP-1 and glucagon receptors; the glucagon arm is studied for effects on hepatic fat.
Investigated for hepatic endpoints in phase 2 work.
Honest note on evidence: Published human data is emerging; treat this profile as preliminary.
Descriptions summarize existing published research and are not claims about outcomes from use. Every citation states its study type and population.
How it compares
| Versus | Attribute | Note |
|---|---|---|
| Retatrutide | Receptor targets | Retatrutide adds GIP; survodutide is GLP-1/glucagon only. |
Reconstitution
Concentration math only: add bacteriostatic water to the vial and the resulting concentration is shown below. This is not usage guidance.
| Vial | Bacteriostatic water | Concentration |
|---|---|---|
| 5 mg | 1 mL | 5 mg/mL |
| 10 mg | 1 mL | 10 mg/mL |
Storage & stability
| State | Temperature | Duration |
|---|---|---|
| Lyophilized (unopened) | -20°C | 24 months |
| Reconstituted | 2–8°C | up to 4 weeks |
Reviews
Reviews are collected post-delivery and screened to exclude any human-use or dosing-outcome claims before publication. They speak to product quality, shipping, and COA accuracy.
“Newer compound but the COA was still per-lot and verified on the portal. No corners cut.”
Product FAQ
Is stock limited?+
This lot is running low (see the live count on the product page). Restock timing is posted when confirmed.
Related compounds

Retatrutide
Triple GLP-1 / GIP / glucagon receptor agonist under study.

Tirzepatide
Dual GIP / GLP-1 receptor agonist, extensively studied.

Semaglutide
GLP-1 receptor agonist with a deep clinical literature.

Cagrilintide
Long-acting amylin analog studied with incretins.